Young Bradley L, Bitzer Alex, Odum Susan, Hamid Nady, Shiffern Shadley, Connor Patrick M
Department of Orthopaedic Surgery, Carolinas Medical Center, Atrium Health Musculoskeletal Institute, Charlotte, NC, USA.
OrthoCarolina Shoulder and Elbow Center, Sports Medicine Center, Charlotte, NC, USA.
JSES Rev Rep Tech. 2023 Apr 25;3(3):318-323. doi: 10.1016/j.xrrt.2023.03.008. eCollection 2023 Aug.
The goal of this study was to estimate the short-term (∼2 years) healthcare costs of failed primary arthroscopic rotator cuff repair (RCR) in the United States.
A review of current literature was performed to estimate the number of RCR performed in the United States in the year 2022 and the rate of progression of these patients to lose repair continuity, reach clinical failure, and progress to nonoperative intervention and revision procedures. A review of the current literature was performed to estimate the costs incurred by these failures over the ensuing 2-year postoperative time period.
The direct and indirect healthcare costs of structural and clinical failure of primary RCR performed in 2022 are estimated to reach $438,892,670 in the short-term postoperative period. The majority of the costs come from the estimated $229,390,898 in nonoperative management that these patients undergo after they reach clinical failure.
The short-term healthcare costs of failed arthroscopic RCR performed in the United States in 2022 are predicted to be $438,892,670. Although RCR improves quality of life, pain, function, and is cost-effective, there remains great potential for reducing the economic burden of failed RCR repairs on the US society. Investments into research aimed to improve RCR healing rates are warranted.
Although RCR improves quality of life, pain, function, and is cost-effective, this study provides evidence that there remains great potential for reducing the economic burden of failed RCR repairs on the US society. Investments into research aimed to improve RCR healing rates are warranted.
本研究的目的是估计美国初次关节镜下肩袖修复术（RCR）失败后的短期（约2年）医疗费用。
对当前文献进行回顾，以估计2022年美国进行的RCR手术数量，以及这些患者修复连续性丧失、达到临床失败、进展为非手术干预和翻修手术的发生率。对当前文献进行回顾，以估计这些失败在术后接下来的2年时间内产生的费用。
2022年进行的初次RCR结构和临床失败的直接和间接医疗费用估计在术后短期内达到438,892,670美元。大部分费用来自这些患者达到临床失败后接受的估计229,390,898美元的非手术治疗。
预计2022年美国关节镜下RCR失败的短期医疗费用为438,892,670美元。尽管RCR可改善生活质量、减轻疼痛、恢复功能且具有成本效益，但仍有很大潜力可减轻RCR修复失败对美国社会造成的经济负担。有必要投资于旨在提高RCR愈合率的研究。
尽管RCR可改善生活质量、减轻疼痛、恢复功能且具有成本效益，但本研究提供的证据表明，仍有很大潜力可减轻RCR修复失败对美国社会造成的经济负担。有必要投资于旨在提高RCR愈合率的研究。
